Dr Patrick Legembre, PhD - University limoges - PhD

Dr Patrick Legembre

PhD

University limoges

PhD

Limoges | France

Main Specialties: Allergy & Immunology, Biology, Biotechnology, Oncology

Additional Specialties: Cell signaling

ORCID logohttps://orcid.org/0000-0001-6649-8049


Top Author

Dr Patrick Legembre, PhD - University limoges - PhD

Dr Patrick Legembre

PhD

Introduction

By education, I’m an immunologist and I now work on understanding the role of Fas and its ligand FasL, which belong to the TNFR/TNF superfamily, in the severity of breast cancers (mainly on triple negative breast cancer) and lupus.

Primary Affiliation: University limoges - Limoges , France

Specialties:

Additional Specialties:

Research Interests:


View Dr Patrick Legembre’s Resume / CV

Education

Jun 2007
Accreditation to supervise research
HDR
Immunology
Sep 2005
University Chicago
Post-doct
Jul 2002 - Sep 2004
University of Chicago
Post-doctoral fellow
Cell biology
Sep 2002
Universite Bordeaux
PhD
Sep 1998 - Jun 2002
Université de Bordeaux
PhD

Experience

Jan 2020
INSERM Senior Researcher (director of Research)
Director of Research
U1262, Université Limoges
Feb 2017
co-founder APOFAS-biotech
Jan 2010
INSERM Senior Researcher (director of Research)
Principal investigator
Université Rennes-1
Dec 2005
INSERM Junior Researcher Universite Bordeaux
Junior Researcher
Université Bordeaux
Jan 2006
INSERM
Director of Research
Centre Eugène Marquis - CRLCC

Publications

62Publications

2142Reads

406Profile Views

1772PubMed Central Citations

CD95 Structure, Aggregation and Cell Signaling.

Front Cell Dev Biol 2020 5;8:314. Epub 2020 May 5.

INSERM U1262, CRIBL, Université de Limoges, Limoges, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fcell.2020.00314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214685PMC
May 2020

CD95/Fas and metastatic disease: What does not kill you makes you stronger.

Semin Cancer Biol 2020 02 6;60:121-131. Epub 2019 Jun 6.

CLCC Eugène Marquis, Équipe Ligue Contre Le Cancer, Rennes, France; Université Rennes, INSERM U1242, Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2019.06.004DOI Listing
February 2020
2 Reads
9.330 Impact Factor

Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interaction.

Bioorg Med Chem Lett 2019 11 7;29(21):126669. Epub 2019 Sep 7.

CLCC Eugène Marquis, INSERM, Univ Rennes 1, UMR1242, rue Bataille Flandres Dunkerque, 35042 Rennes, France; Equipe Ligue Contre Le Cancer, rue Bataille Flandres Dunkerque, 35042 Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2019.126669DOI Listing
November 2019
2.420 Impact Factor

HIV protease inhibitors and autoimmunity: An odd, but promising idea.

Autoimmun Rev 2019 Oct 9;18(10):102370. Epub 2019 Aug 9.

Laboratoire d'Immunologie et Immunogénétique, FHU ACRONIM, Hôpital Pellegrin, Centre Hospitalier Universitaire, place Amélie Raba Léon, 33076 Bordeaux, France; Université de Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux, France; CNRS-UMR 5164, ImmunoConcEpt, Université de Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15689972193017
Publisher Site
http://dx.doi.org/10.1016/j.autrev.2019.102370DOI Listing
October 2019
2 Reads
7.933 Impact Factor

Investigation of Phospholipase Cγ1 Interaction with SLP76 Using Molecular Modeling Methods for Identifying Novel Inhibitors.

Int J Mol Sci 2019 Sep 23;20(19). Epub 2019 Sep 23.

CEISAM UMR CNRS 6230, UFR Sciences et Techniques, Université de Nantes, 44322 Nantes CEDEX 3, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20194721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801593PMC
September 2019
1 Read
2.862 Impact Factor

Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysis.

Bioorg Med Chem Lett 2019 08 5;29(16):2094-2099. Epub 2019 Jul 5.

CLCC Eugène Marquis, INSERM, Univ Rennes 1, UMR1242, rue Bataille Flandres Dunkerque, 35042 Rennes, France; Equipe Ligue Contre Le Cancer, rue Bataille Flandres Dunkerque, 35042 Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2019.07.006DOI Listing
August 2019
2.420 Impact Factor

An insight into the role of the death receptor CD95 throughout pregnancy: Guardian, facilitator, or foe.

Birth Defects Res 2019 03 31;111(4):197-211. Epub 2019 Jan 31.

Department of Environmental toxicology and Chemical Pharmacology, INRS - Institut Armand-Frappier and Center for Interdisciplinary Research on Well-Being, Health, Society and Environment, Laval, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdr2.1470DOI Listing
March 2019
4 Reads

Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cells.

BMC Res Notes 2018 Jun 20;11(1):401. Epub 2018 Jun 20.

COSS (Chemistry Oncogenesis Stress Signaling)-UMR 1242, Inserm, Univ Rennes, CLCC Eugène Marquis, Rue Bataille Flandres Dunkerque, 35042, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-018-3504-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011598PMC
June 2018
9 Reads

Nonapoptotic functions of Fas/CD95 in the immune response.

FEBS J 2018 03 16;285(5):809-827. Epub 2017 Nov 16.

Centre Eugène Marquis, INSERM U1242-COSS, Equipe Labellisée Ligue Contre Le Cancer, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/febs.14292DOI Listing
March 2018
10 Reads
4.001 Impact Factor

CD95 Stimulation with CD95L and DISC Analysis.

Methods Mol Biol 2017 ;1557:11-18

Centre Eugène Marquis, rue Bataille Flandres Dunkerque, 35042, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6780-3_2DOI Listing
February 2018
6 Reads

Study of the CD95-Mediated Non-apoptotic Signaling Pathway: PI3K.

Methods Mol Biol 2017 ;1557:103-110

Centre Eugène Marquis, rue Bataille Flandres Dunkerque, 35042, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6780-3_10DOI Listing
February 2018
8 Reads

Proximity Ligation Assay (PLA) to Evaluate DISC and MISC Composition.

Methods Mol Biol 2017 ;1557:41-48

Centre Eugène Marquis, rue Bataille Flandres Dunkerque, 35042, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6780-3_5DOI Listing
February 2018
6 Reads

Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers.

Recent Pat Anticancer Drug Discov 2016 ;11(3):283-96

Centre Eugène Marquis, INSERM ERL440, Rue Bataille Flandres Dunkerque, 35042 Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574892811666160519113731DOI Listing
March 2017
14 Reads
4 Citations
4.295 Impact Factor

CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice.

Immunity 2016 07;45(1):209-23

Centre Eugène Marquis, Rue Bataille Flandres Dunkerque, 35042 Rennes, France; INSERM ERL440-OSS, Equipe Labellisée, Ligue Contre Le Cancer, 35042 Rennes, France; Université de Rennes 1, 2 Ave. du Prof. Léon Bernard, 35043 Rennes, France; Biosit, Plateforme H2P2, Biogenouest, 2 Ave. du Prof. Léon Bernard, 35043 Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2016.06.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961226PMC
July 2016
101 Reads
5 Citations
21.561 Impact Factor

The cleaved FAS ligand activates the Na(+)/H(+) exchanger NHE1 through Akt/ROCK1 to stimulate cell motility.

Sci Rep 2016 06 15;6:28008. Epub 2016 Jun 15.

Université Nice-Sophia Antipolis, CNRS UMR7370 LP2M, Faculté de Médecine, 28 Avenue de Valombrose 06107 Nice cedex. France and Laboratories of Excellence Ion Channel Science and Therapeutics, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep28008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908414PMC
June 2016
81 Reads
1 Citation
5.080 Impact Factor

Chemotherapy with ceramide in TNBC.

Oncoscience 2015 21;2(10):817-8. Epub 2015 Aug 21.

Centre Eugène Marquis, rue bataille Flandres Dunkerque, Université de Rennes-1, INSERM ERL440, Equipe Labellisée Ligue Contre Le Cancer, rue bataille Flandres-Dunkerque, Rennes, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671935PMC
http://dx.doi.org/10.18632/oncoscience.196DOI Listing
December 2015
10 Reads

A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells.

J Med Chem 2015 Aug 14;58(16):6559-73. Epub 2015 Aug 14.

Université de Rennes-1 , 2 avenue du Prof. Leon Bernard, 35043 Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.5b00991DOI Listing
August 2015
51 Reads
1 Citation
5.450 Impact Factor

Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility.

Oncogene 2015 Feb 17;34(8):996-1005. Epub 2014 Mar 17.

1] Université de Rennes-1, Rennes, France [2] INSERM UMR 1085, IRSET, Rennes, France [3] Equipe Labellisée Ligue Contre Le Cancer, Rennes, France [4] Centre Eugène Marquis, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/onc.2014.55DOI Listing
February 2015
18 Reads
19 Citations
8.460 Impact Factor

The CD95/CD95L signaling pathway: a role in carcinogenesis.

Biochim Biophys Acta 2014 Aug 26;1846(1):130-41. Epub 2014 Apr 26.

Université Rennes-1, 2 Avenue du Professeur Léon Bernard, 35043 Rennes, France; INSERM U1085, IRSET, 2 Avenue du Professeur Léon Bernard, 35043 Rennes, France; Equipe Labellisée Ligue Contre Le Cancer "Death Receptors and Tumor Escape", 2 Avenue du Professeur Léon Bernard, 35043 Rennes, France; Centre Eugène Marquis, rue bataille Flandres Dunkerque, Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2014.04.007DOI Listing
August 2014
51 Reads
15 Citations

CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer.

Cancer Res 2013 Nov 26;73(22):6711-21. Epub 2013 Sep 26.

Authors' Affiliations: Inserm U1085-IRSET, Equipe Labellisée Ligue Contre Le Cancer; Université de Rennes-1; Centre Eugène Marquis, rue bataille Flandres Dunkerque, Rennes; ImmuSmol, 15 Rue Amiral Prouhet, Pessac; Inserm, U1068; Institut Paoli-Calmettes; Aix-Marseille Université, CNRS, UMR 7258, Marseille; ICO-René Gauducheau, Bd J. Monod, Saint-Herblain; Université de Bordeaux; Inserm U1045, Université Bordeaux Segalen; and Inserm U916, Institut Bergonié, Bordeaux, France.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/early/2013/11/07/0
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-1794DOI Listing
November 2013
32 Reads
16 Citations
9.330 Impact Factor

Mycophenolic Acid overcomes imatinib and nilotinib resistance of chronic myeloid leukemia cells by apoptosis or a senescent-like cell cycle arrest.

Leuk Res Treatment 2012 23;2012:861301. Epub 2012 Feb 23.

Laboratoire Hématopoïèse Leucémique et Cibles Thérapeutiques, INSERM U1035, Université Bordeaux Ségalen, 146 Rue Léo Saignat Bat TP 4e étage, 33076 Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/861301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504262PMC
December 2012
14 Reads
1 Citation

CD95-mediated cell signaling in cancer: mutations and post-translational modulations.

Cell Mol Life Sci 2012 Apr 1;69(8):1261-77. Epub 2011 Nov 1.

Université Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-011-0866-4DOI Listing
April 2012
57 Reads
9 Citations
5.810 Impact Factor

CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation.

Proc Natl Acad Sci U S A 2011 Nov 7;108(47):19072-7. Epub 2011 Nov 7.

Université Rennes-1, Institut de Recherche sur la Santé, l'Environnement et le Travail/Equipe Accueil Signalisation et Réponse aux agents infectieux et Chimiques 35043 Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1116946108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223456PMC
November 2011
24 Reads
9 Citations
9.810 Impact Factor

The plasma membrane: a catalyst in the decision to die or not to die?

Recent Pat Anticancer Drug Discov 2011 Sep;6(3):271-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157489211796957810DOI Listing
September 2011
13 Reads
4.295 Impact Factor

Actin-independent exclusion of CD95 by PI3K/AKT signalling: implications for apoptosis.

Eur J Immunol 2011 Aug 4;41(8):2368-78. Epub 2011 Jul 4.

CNRS UMR 5164, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201041078DOI Listing
August 2011
16 Reads
2 Citations
4.034 Impact Factor

Does calcium contribute to the CD95 signaling pathway?

Anticancer Drugs 2011 Jul;22(6):481-7

INSERM U, Institut Bergonié, Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e32834433eaDOI Listing
July 2011
13 Reads
4 Citations
1.891 Impact Factor

S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells.

Gastroenterology 2011 Jun 24;140(7):2009-18, 2018.e1-4. Epub 2011 Feb 24.

Ecole Pratique des Hautes Etudes, Tumor Immunology and Immunotherapy Laboratory, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2011.02.053DOI Listing
June 2011
50 Reads
21 Citations
16.720 Impact Factor

Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.

Eur J Cancer 2010 May 4;46(8):1445-55. Epub 2010 Mar 4.

EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.01.034DOI Listing
May 2010
106 Reads
12 Citations
5.420 Impact Factor

Redistribution of CD95 into the lipid rafts to treat cancer cells?

Recent Pat Anticancer Drug Discov 2010 Jan;5(1):22-8

U858 INSERM, BP84225, 31432 Toulouse cedex 4, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157489210789702190DOI Listing
January 2010
33 Reads
2 Citations
4.295 Impact Factor

An atypical necrotic signal induced by immunosuppressive and anti-viral agents.

Autophagy 2009 Apr 28;5(3):425-7. Epub 2009 Apr 28.

Université de Bordeaux-2, CNRS UMR 5164 and IFR66, 146 Rue Léo Saignat, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/auto.5.3.7963DOI Listing
April 2009
27 Reads
1 Citation
11.753 Impact Factor

Rewinding the DISC.

Arch Immunol Ther Exp (Warsz) 2008 Jan-Feb;56(1):9-14. Epub 2008 Feb 5.

Université de Bordeaux-2, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-008-0002-9DOI Listing
May 2008
11 Reads
8 Citations
3.180 Impact Factor

The HA tag is cleaved and loses immunoreactivity during apoptosis.

Nat Methods 2007 Feb;4(2):107-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nmeth0207-107DOI Listing
February 2007
56 Reads
10 Citations
32.072 Impact Factor

Dominant-negative Fas mutation is reversed by down-expression of c-FLIP.

Cancer Res 2007 Jan;67(1):108-15

Laboratoire Composantes Innées de la Réponse Immunitaire et Différenciation, Centre National de la Recherche Scientifique UMR 5164, University of Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-1415DOI Listing
January 2007
48 Reads
3 Citations
9.330 Impact Factor

Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytes.

J Immunol 2006 Jan;176(2):716-20

Laboratoire Composantes Innées de la Réponse Immunitaire et Différenciation, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5164, University of Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.176.2.716DOI Listing
January 2006
41 Reads
18 Citations
4.922 Impact Factor

Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment.

Mol Cell Biol 2005 Aug;25(15):6811-20

Laboratoire CIRID, CNRS UMR 5164, Université de Bordeaux 2, 146 rue Léo Saignat, Bordeaux 33076, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.25.15.6811-6820.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1190328PMC
August 2005
92 Reads
8 Citations
4.780 Impact Factor

Does CD95 have tumor promoting activities?

Biochim Biophys Acta 2005 May 27;1755(1):25-36. Epub 2005 Jan 27.

The Ben May Institute for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2005.01.001DOI Listing
May 2005
21 Reads
27 Citations

Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness.

J Biol Chem 2004 Nov 3;279(45):46742-7. Epub 2004 Sep 3.

Committees on Immunology and Cancer Biology, Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M404334200DOI Listing
November 2004
18 Reads
18 Citations
4.573 Impact Factor

Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds.

EMBO Rep 2004 Nov;5(11):1084-9

The Ben May Institute for Cancer Research, University of Chicago, 924 E 57th Street, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.embor.7400280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1299175PMC
November 2004
47 Reads
18 Citations
9.055 Impact Factor

The relevance of NF-kappaB for CD95 signaling in tumor cells.

Cell Cycle 2004 Oct 26;3(10):1235-9. Epub 2004 Oct 26.

The Ben May Institute for Cancer Research, Committees on Immunology and Cancer Biology, The University of Chicago, Chicago, Illinios 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.3.10.1194DOI Listing
October 2004
39 Reads
6 Citations

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

EMBO J 2004 Aug 22;23(15):3175-85. Epub 2004 Jul 22.

The Ben May Institute for Cancer Research, Committee on Immunology, The University of Chicago, Chicago, IL 60637-5420, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.emboj.7600325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC514938PMC
August 2004
39 Reads
70 Citations
10.434 Impact Factor

Cutting edge: SDS-stable Fas microaggregates: an early event of Fas activation occurring with agonistic anti-Fas antibody but not with Fas ligand.

J Immunol 2003 Dec;171(11):5659-62

Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5540, Université de Bordeaux II, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.11.5659DOI Listing
December 2003
21 Reads
12 Citations
4.922 Impact Factor

Two CD95 tumor classes with different sensitivities to antitumor drugs.

Proc Natl Acad Sci U S A 2003 Sep 22;100(20):11445-50. Epub 2003 Sep 22.

The Ben May Institute for Cancer Research, University of Chicago, 924 East 57th Street, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.2034995100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC208777PMC
September 2003
46 Reads
29 Citations
9.810 Impact Factor

Top co-authors

Pierre Vacher
Pierre Vacher

Université de Bordeaux 2

13
Sophie Daburon
Sophie Daburon

Université de Bordeaux 2

11
Benjamin Chaigne-Delalande
Benjamin Chaigne-Delalande

National Institutes of Health

9
Thomas Ducret
Thomas Ducret

Université de Bordeaux 2

8
Sebastien Tauzin
Sebastien Tauzin

University of Wisconsin-Madison

8
Jean-Luc Taupin
Jean-Luc Taupin

Université de Bordeaux 2

8
Mickael Jean
Mickael Jean

Université de Rennes 1

7